Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics
Crossref DOI link: https://doi.org/10.3389/fonc.2020.561936
Published Online: 2020-11-16
Update policy: https://doi.org/10.3389/crossmark-policy
Lai, Jiun-I
Tseng, Yu-Jhen
Chen, Ming-Huang
Huang, Chi-Ying F.
Chang, Peter Mu-Hsin
Version of Record valid from 2020-11-16